Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Oligometastatic Disease · Solid Tumor, Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre Léon Bérard, Lyon, France
Contact: Study coordinator (Gwenaëlle GARIN-FOURNIER, PhD) · gwenaelle.garin@lyon.unicancer.fr · +33 (0)4 26 55 68 24
Contact: Principal Investigator (Vincent GREGOIRE, PhD, MD)
Gustave Roussy, Villejuif, France
Contact: Study coordinator (Eric DEUTSCH, PhD, MD) · eric.deutsch@gustaveroussy.fr · +33 (0)1 42 11 42 11
Contact: Principal Investigator (Eric DEUTSCH, PhD, MD)

Study leads

Eric DEUTSCH, PhD, MD
Principal Investigator
Gustave Roussy, Cancer Campus, Grand Paris

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic Sites

Metastatic Disease

Abroad (travel likely)RecruitingPHASE2

Obninsk, Russia

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

Adenocarcinoma · Stomach Neoplasm · Gastroesophageal-junction Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Oligometastatic Disease · Oligoprogression · Toxicity Due to Radiotherapy

Abroad (travel likely)Recruiting

Kelowna, Canada · Prince George, Canada

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

Pancreas Cancer · Oligometastatic

Abroad (travel likely)RecruitingPHASE3

Camden, United States · Voorhees Township, United States